Peer Review History
| Original SubmissionJuly 18, 2023 |
|---|
|
PONE-D-23-21180EndoGeneAnalyzer: a tool for selection and validation of reference genesPLOS ONE Dear Dr. TEIXEIRA, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. First of all, I would like to apologize for really long review process but I was struggling to find reviewers for your manuscript. I somehow expected that as your topic is neglected by many researchers. However, in my opinion, searching for HKGs is very important topic and tools as EndoGeneAnalyzer are of great uses for the community. Nevertheless, both reviewers raised numerous questions regarding your tool. In my eyes, they are meant to improve your manuscript and tool which could bring you more users and citations in the future. Both reviewers in many cases pointed to the same issues. Thus, please try to address all of their concerns. Please submit your revised manuscript by Dec 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Karel Sedlar, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data). 3. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 4. Thank you for stating in your Funding Statement: “This study was supported by Brazilian funding agencies: Coordination for the Improvement of Higher Education Personnel (CAPES; to E.B.T), the National Council of Technological and Scientific Development (CNPq grant number [404213/2021-9 to CAM-N; Productivity in Research PQ scholarships to P.P.A, A.S.K., and CAM-N]), and the Cearense Foundation of Scientific and Technological Support (FUNCAP grant number [P20-0171-00078.01.00/20 to CAM-N]); we also thank PROPESP/UFPA for the publication payment.” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 6. Thank you for stating the following in the Acknowledgments Section of your manuscript: We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This study was supported by Brazilian funding agencies: Coordination for the Improvement of Higher Education Personnel (CAPES; to E.B.T), the National Council of Technological and Scientific Development (CNPq grant number [404213/2021-9 to CAM-N; Productivity in Research PQ scholarships to P.P.A, A.S.K., and CAM-N]), and the Cearense Foundation of Scientific and Technological Support (FUNCAP grant number [P20-0171-00078.01.00/20 to CAM-N]); we also thank PROPESP/UFPA for the publication payment.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Comments on the app • In the Shiny app, on the “Gene Reference Analysis” page – please provide some extra written context to help with interpretation. For example, that the numbers in the topmost table are p-values, with significant p-vals in red. For the Normfinder Analysis, a brief description of how to interpret results to select the optimal combination of reference genes would be helpful (either on this page or the tutorial page). For example, what range of stability is acceptable for a gene to be retained as a reference, and in what range should one consider removing that gene before proceeding with gene expression analysis. Indeed, the ReadMe/Tutorial should provide a tutorial using the sample data for how to correctly analyse this dataset – what parameters provide evidence that a reference gene should be included/excluded, how this affects the interpretation of gene expression results – e.g. the tutorial could show how not excluding a reference gene with differential expression results in an incorrect conclusion on the differential analysis page. While the MS does go some way to assist in interpretation of results, the authors should assume that some users may access the app without reading the paper. • The same comment applies to the Differential Analysis page. Please provide some context to assist in interpreting results. The MS (line 98) states that fold-change results are provided on this page, but the word “fold” is not used on this page at all, making it potentially difficult to interpret/understand the provided results (especially to researchers new to the field). Also suggest renaming “Differential Analysis” to “Differential Expression Analysis” or similar (to make clear that this page is about analysing the actual results of a gene expression experiment, after prior reference gene selection. • On the Gene Reference samples page – it would be useful to have functionality to add outliers back into the analysis if the user chooses, so that the impact of removal and retention of these samples can more easily be explored. Also suggest adding some additional wording about what the two options for the radio buttons mean – this is clearer in the MS (lines 126-127) then in the software itself. • On the Gene Reference Analysis page – Have you considered adding an analysis to determine the optimal number and/or combination of reference genes? Many of the algorithms do this. Using the intragroup variance would be a good place to start. As stated in the original Normfinder paper: “Intragroup variance estimates provide a natural way of identifying the number of genes to include. The optimal number of genes is reached when addition of a further gene leads to a negligible reduction in the average of the gene variance estimates.” • On the Gene Reference Analysis page – please provide a key for abbreviations (IGroup = intergroup, SD = standard deviation etc) • On the “Differential Analysis” page – it might be useful to offer an option to download the ggplot script as well as the PDF of the figure. This would allow users to edit the figure for publication. Also an option to download the tables. Figure and table download options on the Data Summary, Gene Reference Samples and Gene Reference Analysis pages would also be useful, for example so outputs can be saved in electronic notebooks. These are just suggestions though! • I found the timing out somewhat annoying. Would it be possible to, for e.g., add a popup warning box along the lines of “you are about to be disconnected, do you wish to continue this session?". Or at least note on the tutorial page the amount of inactivity time a user has before they are disconnected from the server. Continually having to reupload the data was quite tedious. • It would be helpful if the sample data file had a larger set of candidate reference genes, with some that obviously show differential expression and should therefore be excluded, and others that are very stable and should be included. In the currently provided dataset, interpretation is a little ambiguous (each ref gene is stable for some comparisons but not others. While this likely mimics real-world data much of the time, for the purposes of a demo dataset, more clear-cut interpretation would be useful). The file should also include more (and some very obvious) sample outliers. Comments on the MS • Introduction – please add at least one more sentence to connect between generic description of RT-qPCR (lines 41-42) and selection of reference genes (42-44). In what way is RT-qPCR useful for quantifying gene expression, what are reference genes, and why are they important – how do they normalise data? Apart from minimising differences in CT between treatment groups, what other properties are important for ideal reference genes (ubiquitous expression etc). Although this is a brief communication, I think a little more context in these opening sentences of the introduction would be helpful to provide context for why your software can play an important role in the field. • Line 66 – none of the authors of Normfinder are authors of the current publication, and they are also not mentioned in the acknowledgements section. Please confirm that they have provided permission to recreate their algorithm in your app, and acknowledge them accordingly. • Lines 187-217 – in the MS the ‘Gene Reference Analysis’ is discussed before the ‘Gene Reference Samples’ tab. But in the app, the gene ref samples tab is before the gene ref analysis tab. Please reorder either the MS or the app to be consistent. The order should be whichever process should occur first (ref gene ID or outlier removal) is discussed first in the MS and is the first of these two tabs in the app.. • The figures are based on a more comprehensive example dataset than provided as the example data file in the app. For example, RPLPO is not in the sample data, neither is TBP. HPRT is in the sample data but not in Fig4. There are more outliers in the Figure 4 than the provided dataset. Line 205 refers to condition 3, but provided file only has conditions 1 and 2. It would be useful if the figures in the MS where based on the same dataset as the provided sample dataset. Minor comments Line 30 – change ‘instrument’ to ‘platform’ Line 31 – amend to ‘an analysis tool to assist in decision making’ Line 34 – break into two sentences ‘under investigation. This interactive…’ Lines 32 and 41 – spell out RT-qPCR at first use (both in abstract and main body of MS) Lines 55-57 – I would reword slightly. Nothing wrong with those reference genes per se, but need to be validated as stable in the particular context of the study. Lines 59-60 – suggest citing reference directly after each algorithm, rather than grouping all refs at end of sentence Line 135 – add fullstop after ‘genes’ Lines 148-149 – please add some further information about how to interpret NormFinder results and use these to select an optimal set of reference genes. Line 157 – please provide reference for the 2-ΔΔCT method. Line 183 – remove ‘meticulously constructed’ Lines 197-203 – change ‘screen’ to ‘table’ or ‘analysis’ Line 231 – change ‘the’ to ‘a’. RNAseq is also a very standard and reliable method these days. Line 246 – remove ‘firstly’ or add other points to the sentence. Lines 276 & 312 – same reference Reviewer #2: Dear Authors, I have carefully reviewed your manuscript on the "EndoGeneAnalyzer," a tool for the analysis of candidate reference genes for RT-qPCR studies. Unfortunately, I must express my concerns regarding the quality and completeness of the manuscript. While the idea behind the tool is promising, several critical issues need to be addressed before the paper can be considered for publication. Below, I've outlined my specific concerns and suggestions for improvement: 1. Data Origin and Description: - The manuscript lacks a clear explanation of the origin of the test data used in the analysis. The phrase "To illustrate the usefulness of the EndoGeneAnalyzer, we used the RT-qPCR data found at " ext-link-type="uri" xlink:type="simple">https://npobioinfo.shinyapps.io/endogeneanalyzer/" is insufficient. You need to provide a comprehensive description of how you obtained the RT-qPCR data, including data sources, collection methods, and any relevant details. 2. Methodological Issues: - There are issues with the method for identifying outliers that are unclear. It's vital to provide a detailed and transparent explanation of the outlier detection process. - The use of boxplots combined with dots for data visualization is questioned. Authors should justify this choice or consider alternative visualization methods. - The origin of values in the table "Reference of genes per group" / "Gene Reference by Group" and the color-coding is not adequately explained. Clarify what the values represent and the rules for color-coding. - The paper lacks a clear rationale for the choice of statistical tests for assessing the stability of reference genes. Additionally, it does not compare the proposed tool with existing reference gene selection methods, such as NormFinder, geNorm, BestKeeper, RefGenes, or RefFinder, to establish its superiority. - The reasons for conducting differential analysis and normality tests are unclear. Authors need to provide a more comprehensive description of how these steps aid in the selection of reference genes. 3. Conclusion: - The conclusion is notably brief and fails to adequately summarize the findings. It lacks an overall assessment of the tool's effectiveness and significance. 4. Inconsistencies and Confusing Statements: - The reference to "Postgraduate program in Biotechnology, Federal University of Pará, Belém, Pará, Brazil" as the institution appears unusual and should be clarified. - Several sentences throughout the manuscript are confusing and should be rephrased for clarity such as lines 31-34 and 54-57. - The use of "Ct (threshold cycle)" is inconsistent with MIQE guidelines, which recommend "Cq (quantification cycle)" values. - Address the ambiguity in the statement "ΔCt greater or less than 2" (Line 124) for better clarity. - Correct the statement "(p-value in reference genes between the studied groups or conditions" (Line 137) for clarity. 5. References: - Ensure that references are correctly linked to their respective tools (line 60), and provide an accurate reference list. - Correct punctuation and grammar in the text, including missing commas. 6. Figures: - Figures 2, 3, 4, and 5 do not correspond with the current state of the tool, leading to confusion. Update these figures to accurately represent the tool. - Figure 1 is misleading due to the use of dotted lines. Reconfigure the workflow diagram to eliminate confusion and better summarize the steps for users. 7. Tool Inconsistencies: - Address inconsistencies in the tool's interface and the manuscript regarding the naming of sections and options. - Resolve issues with the "Update Target Gene" button not functioning correctly. - Clarify the purpose and effects of the "Select one or more Genes" option in the tool. - Make sure that the results in the NormFinder analysis are presented in a clear and understandable manner. - Add titles to all sections in the Differential Analysis tab for clarity. 8. Data Saving and Reporting: - Consider implementing a feature to save the results of all analyses. - Explore the possibility of generating downloadable reports for users, which can enhance the utility of the tool. Overall, I believe your manuscript and tool require substantial revisions and clarifications to meet the standards for publication. Addressing the issues, I raised could substantially improve the quality and user-friendliness of your tool and its associated documentation a thus, bring you more users in the future. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-21180R1EndoGeneAnalyzer: a tool for selection and validation of reference genesPLOS ONE Dear Dr. TEIXEIRA, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 04 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-emailutm_source=authorlettersutm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Karel Sedlar, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: While you have already done substantial improvements to both, manuscript and your tool, there is still need for additional improvement as both reviewers raised numerous, yet only minor, concerns. Please do no prepare your revision in hurry. I am aware that the reviewing process is quite lengthy for your paper but the manuscript must meet publication criteria before it can be accepted. Please consider detailed proofreading of your manuscript and try to eliminate any other mistakes. The concerns that reviewers raised are mostly formal, so I believe you should be able to correct it quite easily. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Well done to the authors for addressing my comments, I think the improvements to the app will make it much easier to use. My remaining comments are largely minor and can be easily addressed. Comments (all line numbers relate to the tracked changes version of the MS) Line 31 – change to ‘tool to assist’ Line 32 – lower case Q Line 46 – remove The Line 63 – only as it pertains to gene expression studies. RT-qPCR is used for many other purposes as well. Lines 65-67 – This sentence should not be a paragraph, instead, make it the first sentence of the previous paragraph. Lines 72-74 – cite Chapman and Waldenström for this point (stability of ref genes within study context) Line 206 – remove second ‘the’ on this line Some of the wording in the tutorial section of the app needs proof-reading (perhaps by a native English speaker) for clarity. Have you considered having an option for Bonferroni (or other method) correction for multiple comparisons in the Differential Expression Analysis? Reviewer #2: The revised manuscript and corresponding application have undergone significant improvements; however, some of my previous concerns were not fully addressed. Comments on the manuscript: I appreciate the creation of a comprehensive tutorial page for your tool. Nevertheless, some information is missing in the manuscript. The method for outliers removal, a previous concern of mine, is now clearly described in the tutorial page but not adequately addressed in the manuscript (lines 143-144). Additionally, the new functionality of restoring outliers is not mentioned in the manuscript. While the authors provided a conclusion for their manuscript, the sentences are overly complicated, hindering understanding, and contain grammar mistakes. The conclusion should also mention the differential expression analysis as one of the additional features of this tool. Please delete the last sentence. Regarding the grammar and flow of the text, I recommend having a native speaker review and edit the whole manuscript. Comments on the figures: Fig 1: Correct the name of third step from: "Gene Reference Sample" to "Gene Reference Samples". Fig 2: Check the description of this figure in the manuscript. Change "Ct" to "Cq". Fig 4: The values in the figure are currently presented only in black and white, despite the description referencing values highlighted in red. To ensure accuracy, update the figure to include the specified coloration. Additionally, align the numbering format consistently between the figure and its description (e.g., use 1, 2, 3 in both). Furthermore, incorporate the respective p-values associated with the color change into the figure description. This ensures that the significance of the color variation is appropriately communicated in the context of the data presented. Other minor comments: Lines 32 + 41: According to the MIQE guidelines (Nomenclature 1.1) RT-qPCR stands for "reverse transcription quantitative real-time polymerase chain reaction". Line 55: Explain the meaning of Cq here. Lines 58 – 61: Check the grammar and clarity of this sentence. Firstly, correct "data normalization process to expression comparison" to "data normalization process for expression comparison". Secondly, consider making the last addition a standalone sentence: "The normalization of data using reference genes involves correcting errors that arise from the initial concentration of RNA/cDNA. " Line 67: Check references on this line. Either put respective reference after mentioned gene or put all references at the end of the sentence into single brackets. Line 128: Delete comma in this sentence. Line 150: Correct "Reference of genes by group" to "Gene Reference by group" to be consistent with the tool. Lines 163 + 165: Check equations, especially the summation symbols and remove word "group" from the summation symbol, it is redundant. Line 164: Remove this line. Line 200: Change "tutorial" to "Tutorial". Line 226: Change "meanRef" to "MeanRef". Line 269: Check references on this line. Put all references at the end of the sentence into single brackets. Comments on the App: Regarding the "Update Target Gene": I was testing your tool and I have selected several genes and pressed the "Update Target Gene" button. After that I tried to unselect any targeted genes and press this button again, but nothing has changed and targets stayed the same. I do not think this a desirable feature. Regarding this concern "Clarify the purpose and effects of the "Select one or more Genes" option in the tool.": Although the tutorial and the tool provide an explanation now, I would recommend to change the title "Select one or more Genes" to "Selected Reference Genes" to be more intuitive. On the "Gene Reference Analysis" tab change all occurrences of "Normfinder" to "NormFinder". On the "Tutorial" tab: Point 1: Change "meanCT" to "mean Cq". Point 2,3 and 5: Corresponding figures have on y-axis "meanCT", change it to "meanCq". Point 5.2: Here, you mention "2^-ΔCq" and in the manuscript "2-ΔΔCq" formula. Please correct the Tutorial page for consistency and check grammar. Finally, let me make two more suggestions for the tool. Regarding the "Gene Reference Samples" tab: I would recommend to add a short description to outlier removal methods, so user can read the description here and decide which method to use. I really like the added description for the "Gene Reference Analysis" tab, which made the analysis easier. I believe that this tab should be treated in the same way and this addition would make it more user-friendly. Create a new tab in the tool called "About". There, provide your contact information for the users as you have also added a warning to the upload page saying "An error has occurred. Check your logs or contact the app author for clarification." but contact information is missing. I would also recommend to provide a link to GitHub page with your code and keep your GitHub page with codes updated. Users can leave feedback there, if they run into some problems, or if they request a new feature to be added. In summary, commendable progress has been made in refining the manuscript and its corresponding application; however, there are still areas that require attention. Focusing on specific concerns, particularly in enhancing clarity, consistency, and functionality, will undoubtedly contribute to the continuous improvement and effectiveness of the tool. The commitment to elevate the overall quality and user experience of both the manuscript and the application is evident, and I look forward to seeing the implementation of these valuable improvements for the benefit of users and the advancement of your tool within the scientific community. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
EndoGeneAnalyzer: a tool for selection and validation of reference genes PONE-D-23-21180R2 Dear Dr. TEIXEIRA, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Karel Sedlar, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Congratulations! I believe your contribution will be of great use for the community. Special thanks also belongs to reviewers. I am once againg sorry it took so long to get them but it was not easy to get specialists in your specific field. Nevertheless, their thorough reviews helped to improve your manuscript and tool a lot. Reviewers' comments: |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .